Merck Sues Novartis Unit Over Cancidas ANDA
Merck & Co. Inc. has accused Novartis AG subsidiary Sandoz Inc. of patent infringement through its efforts to introduce a generic version of anti-fungal drug Cancidas....To view the full article, register now.
Already a subscriber? Click here to view full article